Primary analysis of MASTERKEY-265 phase 1b study of talimogene laherparepvec (T-VEC) and pembrolizumab (pembro) for unresectable stage IIIB-IV melanoma Conference Paper uri icon

authors

  • Dummer, Reinhard
  • Long, Georgina V
  • Ribas, Antoni
  • Puzanov, Igor
  • Michielin, Olivier
  • VanderWalde, Ari
  • Andtbacka, Robert HI
  • Cebon, Jonathan
  • Fernandez, Eugenio
  • Malvehy, Josep
  • Olszanski, Anthony J
  • Gajewski, Thomas F
  • Kirkwood, John M
  • Gause, Christine
  • Chen, Lisa
  • Kaufman, David R
  • Chou, Jeffrey
  • Hodi, F Stephen

publication date

  • 2016